Intravitreal ranibizumab, photodynamic therapy, and vitreous surgery for the treatment of juxtapapillary retinal capillary hemangioma

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 249, Issue 4, 2011, Pages 625-627

  Fong, Angie H C ^a   Li, Kenneth K W ^a,b,c   Wong, David ^a,b,c  

^a QUEEN MARY HOSPITAL   (Hong Kong)

^b UNITED CHRISTIAN HOSPITAL   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

RANIBIZUMAB; TRIAMCINOLONE;

ADULT; CAPILLARY HEMANGIOMA; CASE REPORT; DISEASE ASSOCIATION; EYE EXAMINATION; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; IMAGE ANALYSIS; JUXTAPAPILLARY RETINAL CAPILLARY HEMANGIOMA; LETTER; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROGNOSIS; TREATMENT RESPONSE; VISUAL ACUITY; VITRECTOMY; VON HIPPEL LINDAU DISEASE;

ADULT; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; EPIRETINAL MEMBRANE; FEMALE; FLUORESCEIN ANGIOGRAPHY; HEMANGIOMA, CAPILLARY; HUMANS; INTRAVITREAL INJECTIONS; PHOTOCHEMOTHERAPY; RETINAL NEOPLASMS; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

EID: 79955571616     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-010-1453-3     Document Type: Letter

References (11)

1. Singh AD, Nouri M, Shields CL, Shields JA, Perez N (2002) Treatment of retinal capillary hemangioma. Ophthalmology 109 (10):1799-1806
2. Schmidt-Erfurth UM, Kusserow C, Barbazetto IA, Laqua H (2002) Benefits and complications of photodynamic therapy of papillary capillary hemangiomas. Ophthalmology 109(7):1256-1266 (Pubitemid 34700915)
3. Grover S, Murthy RK et al (2009) Normative data for macular thickness by high-definition spectral-domain optical coherence tomography (spectralis). Am J Ophthalmol 148(2):266-271
4. Warner TD (1999) Relationships between the endothelin and nitric oxide pathways. Clin Exp Pharmacol Physiol 26(3):247-252
5. Wang W, Dentler WL, Borchardt RT (2001) VEGF increases BMEC monolayer permeability by affecting occludin expression and tight junction assembly. Am J Physiol Heart Circ Physiol 280(1):434-440
6. Chan CC, CollinsAB, Chew EY (2007) Molecular pathology of eyes with von Hippel-Lindau (VHL) disease: a review. Retina 27(1):1-7
7. Mennel S, Meyer CH, Callizo J (2009) Combined intravitreal antivascular endothelial growth factor (Avastin) and photodynamic therapy to treat retinal juxtapapillary capillary haemangioma. Acta Ophthalmol Feb 12 [Epub ahead of print]
8. Tzekov R, Lin T, Zhang KM, Jackson B, Oyejide A, Orilla W, Kulkarni AD, Kuppermann BD, Wheeler L, Burke J (2006) Ocular changes after photodynamic therapy. Invest Ophthalmol Vis Sci 47(1):377-385 (Pubitemid 46780839)
9. Figueroa MS, Contreras I, Noval S (2009) Anti-angiogenic drugs as an adjunctive therapy in the surgical treatment of diabetic retinopathy. Curr Diabetes Rev 5(1):52-56
10. Steven P, Laqua H, Wong D, Hoerauf H (2006) Secondary paracentral retinal holes following internal limiting membrane removal. Br J Ophthalmol 90(3):293-295 (Pubitemid 43328661)
11. Bakri SJ, Couch SM et al (2009) Same-day triple therapy with photodynamic therapy, intravitreal dexamethasone, and bevacizumab in wet age-related macular degeneration. Retina 29(5):573-578